Möbius and Prenatal Exposure to Misoprostol. Case Report

DOI:  https://doi.org/10.12804/revsalud13.03.2015.10

Article Sidebar

PDF (Español (España)) HTML (Español (España)) Lector Inteligente (Español (España)) ePub (Español (España))

Issue: Vol. 13 No. 03 (2015)
Section Case Study


Keywords: Congenital abnormalities Möbius syndrome Misoprostol Teratogens Abnormalities Drug-induced Pregnancy.

Main Article Content

Authors

Julián Andrés Ramírez-Cheyne
Paola González
Isabella Rojas
Wilmar Saldarriaga
Carolina Isaza
Harry Pachajoa

Abstract

Möbius syndrome is a congenital paralysis of the seventh cranial nerve that may be associated with involvement of other cranial nerves or other systems. In the United States frequencies from 0.002 to 0.0002 % of all births, and 1/ 50 000 newborns have been calculated. The aim of the study was to present a case of a newborn with Möbius syndrome prenatally exposed to Misoprostol, detected in a third level hospital, under the parameters of the Latin American Collaborative Study of Congenital Malformations (ECLAMC). Literature search focused on the association of prenatal exposure to Misoprostol and congenital malformations, was realized. Case Presentation: New­born with phenotypic characteristics of Möbius syndrome, 16 -year-old mother with history of use of Misoprostol 200 mcg vaginally and 200 mcg orally during the fourth week of gestation. Discussion: Facial palsy and congenital musculoskeletal anomaly have to be established in order to diagnose Möbius syndrome, the patient meets both. Prenatal exposure to Misoprostol has been associated with the occurrence of birth defects, mainly Möbius syndrome and limb defects of terminal transverse type. One of the teratogenic mechanisms proposed for Misoprostol is vascular disruption, as we propose it could be in this case. 

How to Cite
Ramírez-Cheyne, J. A., González, P., Rojas, I., Saldarriaga, W., Isaza, C., & Pachajoa, H. (2015). Möbius and Prenatal Exposure to Misoprostol. Case Report. Revista Ciencias De La Salud, 13(03), 505–511. https://doi.org/10.12804/revsalud13.03.2015.10
References

Palmer C. Möbius Syndrome. Medscape [internet] 2012. [citado 2014 ene 15] Disponible en: http:// emedicine.medscape.com/article/1180822-overview

Herrera C, Mendieta P, Muzzio L. Reporte de caso clínico: síndrome de Möbius. Rev Med Fcm-Ucsg. 2010;16(3):237-42.

Vargas FR, Schuler-Faccini L, Brunoni D, Kim C, Meloni VF, Sugayama SM, et al. Prenatal exposure to Misoprostol and vascular disruption defects: a case - control study. Am J Med Genet 2000;95:302-6.

Dal Pizzol TS, Knop FP, Mengue SS. Prenatal exposure to Misoprostol and congenital anomalies: systematic review and meta-analysis. Reprod Toxicol 2006;22:666-71.

Henderson JL. The congenital facial diplegia syndrome: clinical features, pathology and etiology. Brain. 1939;62:381-403.

Möbius PJ. Uber angeboren doppelseitige abducens-facialis-lahmung. Munchen Medizinische Wo-chenschrift. 1888;35:91-4.

Möbius PJ. Uber infantilen kernschwund. Munchen Medizinische Wochenschrift. 1892;39:17-58.

Verzijl HT, van der Zwaag B, Cruysberg JR, Padberg GW. Möbius syndrome redefined: a syndrome of rhombencephalic maldevelopment. Neurology. 2003;61(3):327-33.

Ziter FA, Wiser WC, Robinson A. Three-generation pedigree of a Möbius syndrome variant with chromosome translocation. Arch. Neurol. 1977;34:437-42.

Slee JJ, Smart RD, Viljoen DL. Deletion of chromosome 13 in Möbius syndrome. J. Med. Genet. 1991;28:413-14.

Nishikawa M, Ichiyama T, Hayashi T, Furukawa S. Möbius-like syndrome associated with a 1;2 chro-mosome translocation. Clin. Genet. 1997;51:122-23.

Donahue SP, Wenger SL, Steele MW, Gorin MB. Broad-spectrum Möbius syndrome associated with a 1;11 chromosome translocation. Ophthalmic Paediat Genet. 1993;14:17-21.

Norman JE, Thong KG, Baird DT. Uterine contractility and induction of abortion in early pregnancy by Misoprostol and mifepristone. Lancet 1991;338:1233-6.

Costa SH. Commercial availability of Misoprostol and induced abortion in Brazil. Int J Gynaecol Obstet 1998;63:S131-9.

Schüler L, Ashton PW, Sanseverino MT. Teratogenicity of Misoprostol. Lancet 1992;339:437-8.

Schüler L, Pastuszak A, Sanseverino TV, Orioli IM, Brunoni D, Ashton-Prolla P, et al. Pregnancy outcome after exposure to Misoprostol in Brazil: a prospective, controlled study. Reprod Toxicol. 1999;13:147-51.

Cavieres MF. Toxicidad del Misoprostol sobre la gestación. Revisión de la literatura. Rev Med Chile. 2011;139: 516-23.

Ramírez-Cheyne J, Pachajoa H, Isaza C, Saldarriaga W. Síndrome de aglosia-adactilia y exposición prenatal a Misoprostol ¿relación causal o casual? Reporte de un caso. Rev Colom Obstet Ginecol 2008;59(3):248-52.

Pachajoa H. Pentalogía de Cantrell en un recién nacido expuesto en útero a Misoprostol. Rev Chil Obstet Ginecol 2010;75(1):47-9.

Pachajoa H, Isaza C. Primer caso de síndrome de Möbius-Poland en niño expuesto prenatalmente a Misoprostol. Neurología 2011;26:502-3.

Pachajoa H, Isaza C. Síndrome de Möbius, comunicación interventricular asociado a exposición prenatal a Misoprostol. Rev Chil Pediatr 2013;84(4):425-28.

Isaza C, Saldarriaga W, Pachajoa H. Uso inadecuado de Misoprostol. ¿Un problema de salud pública? Colomb Med. 2008;39(2):61-5.

Los FJ, Brandemburg H, Niermeijer MF. Vascular disruptive síndromes after exposure to Misoprostol or chorionic villus sampling. Lancet. 1999;353:843-4.

Webster WS, Abela D. The effect of hypoxia in development. Birth Defects Research (Part C). 2007;81:215-28.

Yip SK, Tse A, Haines CJ, Chung T. Misoprostol’s effect on uterine arterial blood flow and fetal heart rate in early pregnancy. Obstet Gynecol 2000;95:232-5.

Query Statistics

Downloads

Download data is not yet available.
Publcation metrics

1309 836




 

Published articles are solely the authors’ responsibility and do not commit the Editorial Committee nor the Scientific Committee. The copyrights belong to the Revista Ciencias de la Salud, therefore, total or partial reproduction of the published material is forbidden, unless there is a previous authorization.